{"expires": 1766437136, "value": "{\"moat_score\": 0.8, \"reasoning\": \"VRTX has a strong competitive moat due to its high gross margin, operating margin, and ROE, indicating a profitable business model. Its high debt/equity ratio is a concern, but the company's position in the healthcare sector, particularly in the specialty of cystic fibrosis treatment, provides a level of protection and pricing power, contributing to its sustainable competitive advantage.\"}"}